Patients with MS and comorbid psychiatric conditions have increased severity of subsequent neurological disability.
Collaborative care intervention does not improve health in chronic heart failure, but alleviates depression and fatigueApril 19, 2018
Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA), a collaborative care intervention combining symptom and psychosocial care, did not improve heart failure-specific health status in chronic heart disease compared with usual care. When compared with usual care, CASA did improve secondary outcomes of depression and fatigue.
These results highlight the potential utility of incorporating personality functioning assessments into bipolar disorder I treatment plans to fully restore global functioning during remission.
These data indicate a potential association between prenatal SSRI exposure and the development of the fetal amygdala-insula circuit, possibly via anomalous serotonin signaling.
The prevalence of depression and anxiety are increased among survivors of colorectal cancer.
Mothers struggling with depression may benefit from additional breastfeeding education and support.
Recognizing the increased risk for mood disorders in children with ASD and ADHD may be useful for clinicians and parents in developing proper screening and treatment strategies.
Major depressive disorder with psychotic features had comparative long-term outcomes with schizophrenia, schizoaffective disorder, and bipolar disorder.
Researchers noted that therapeutic interventions focused on GDF-15 levels may decrease mortality risk and increase longevity in patients with bipolar disorder.
Children of first-cousin consanguineous parents have increased odds of mental health issues and needing antidepressant medications.
Investigators assessed the prevalence and risk factors associated with symptoms of anxiety and depression in adolescents with HIV and those without infection but affected by HIV.
Patients associated with caregivers who received family-focused treatment also demonstrated a significant decrease in depressive symptoms compared with patients associated with caregivers in the control group.
Selective serotonin reuptake inhibitors and other antidepressants, such as tricyclic antidepressants, are associated with increased adverse outcomes in patients aged 20 to 64 years diagnosed with depression.
Among the somatic comorbidities evaluated were acne, type 1 diabetes, Down syndrome, hypertension, inflammatory bowel diseases, inflammatory joint diseases, metabolic syndrome, obesity, pilonidal sinus, and thyroid disorders.
Ceasing regular exercise increases depressive symptoms, particularly in women.
Individuals with chronic pain and comorbid depression may experience higher levels of stigma related to their conditions compared with patients with chronic pain alone.
Many non-pregnant women of childbearing age are suffering from untreated depression.
The incidence and prevalence of psychiatric disorders such as depression, anxiety, and bipolar disorder are higher in the rheumatoid arthritis population.
Neuropathic pain has been linked with negative outcomes including psychological distress.
These findings challenge existing concerns about the association of light therapy with manic switching and may be useful for clinicians in developing treatment strategies for patients with bipolar disorder.
Practice guidelines have been updated to assist primary care physicians in the screening and treatment of adolescent depression.
These results indicated a persistence of depressive and antisocial symptoms and related behavioral patterns far beyond what has been demonstrated in prior research.
Quality of Life May Be Improved in Chronic Pain With Multidisciplinary Social Cognitive InterventionFebruary 22, 2018
Social cognitive intervention may lead to improvements in health-related QoL in patients with chronic pain.
Treatment initiation for depression is suboptimal in the primary care setting despite availability.
Low-strength evidence suggests that cranial electrical stimulation (CES) may be moderately beneficial for patients with depression and anxiety. There was insufficient evidence that CES provides clinically important benefit for fibromyalgia, neuromusculoskeletal pain, degenerative joint pain, headache, depression, or insomnia.
By bringing together published and unpublished data from more than 500 double-blind, randomized, controlled trials, this study represents the best currently available evidence base to guide the choice of pharmacologic treatment for adults with acute depression.
Alcohol use disorder and depression were both associated with higher disengagement from antiretroviral therapy for patients with HIV.
Michael Thase, MD, comments on the potential for lithium in drinking water as a psychiatric prophylactic agent.
The issue of whether and how prenatal SSRI exposure affects offspring has remained murky.
Fair to poor concordance was seen between dermatologist assessment and patient self-reporting.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Clinician Insight: Exploring the Link Between Bipolar Disorder and Binge Eating Disorder
- #MeToo: Helping Victims Cope With Sexual Harassment
- Association Between Psychosis and Development of Dementia in Older Men
- Psychosis Could Be a Potential Side Effect of Steroid Treatment in Kids
- Personality Functioning Associated With Global Functioning in Bipolar Disorder I
- Nutritional Influences on Bipolar Disorder in Children
- Triiodothyronine in the Treatment of Bipolar Depression
- Old Challenges and New Directions in Managing Tardive Dyskinesia
- Similar Rates of Childhood Trauma in Schizophrenia and Substance Use Disorders
- Potential for SERMs as Adjunctive Therapy for Schizophrenia
- Childhood Insulin Resistance Associated With Later Psychosis
- Lamotrigine Similar to Placebo in Treating Borderline Personality Disorder
- Glucocorticoids May Increase Risk of Developing Schizophrenia Spectrum Disorder
- Predictors, Incidence of Long-term Use of Benzodiazepines, Z-Drugs in Bipolar Disorder
- Cardiometabolic Dysregulation Associated With Cognitive Decline Mediated by Depression